Tag: PAD

Black patients in areas with lowest PAD rates disproportionally at higher...

It’s the among the most topical areas of discussion in current U.S. cultural life: Black people face disparities in terms of healthcare outcomes. And...

SVN to host virtual annual meeting July 15

The Society for Vascular Nursing (SVN) 38th Annual Conference—a virtual meeting—will be held from 6 to 9:30 p.m. Central Daylight Time Wednesday, July 15. In...

International Lecture: Endovascular colossus discusses new PAD therapy

A new therapy of hydration and oncotic pressure of plasma helped 100% of certain elderly peripheral artery disease (PAD) patients in terms of pain,...

SVS pilots SET app for peripheral artery disease patients

Doctor-prescribed and -supervised exercise therapy is going digital. The Society for Vascular Surgery (SVS) will begin piloting a ground-breaking app for Supervised Exercise Therapy...

SVS in transition: A look back, a look ahead

Each Society for Vascular Surgery (SVS) president wishes for a memorable annual meeting, outgoing SVS president Kim Hodgson, MD, noted during his State of...

TOBA III clinical trial results published

Intact Vascular has announced the peer-reviewed publication of its Tack optimized balloon angioplasty (TOBA) III 12-month clinical trial results in the Journal of Vascular Surgery. The multi-center, single-arm,...

Technology drives vascular future

Decades ago, “picture” phones were an idea straight out of science fiction. As the saying goes, the future is now. FaceTime and Skype are...

Quality: Global Vascular Guidelines pocket guide coming soon

The Global Vascular Guidelines (GVG), extensively researched and written by an international committee of leading vascular experts, will soon be available as a pocket...

Clopidogrel exposure along with aspirin and rivaroxaban should be ‘minimized or...

“More bleeding with background clopidogrel, even if not severe by adjudication, may be associated with broad consequences, including discontinuation of therapies. In the absence...

Combining aspirin with rivaroxaban reduces risk equally in presence or absence...

In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative degree of benefit on coronary, cerebrovascular and peripheral endpoints in patients...

Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularization

Treatment with aspirin plus rivaroxaban following lower-extremity revascularization in patients with peripheral arterial disease (PAD) leads to a 15% reduction in the risk of...